Company officials boasted that the t:connect mobile app is now the first smartphone app FDA-cleared for insulin delivery on both the iOS and Android operating systems.
Tandem Diabetes Care plans to roll out the mobile bolus feature update in the U.S. throughout the spring in a series of limited launch groups that it has already selected. The company plans an expanded launch later this summer.
Get the full story on our sister site Drug Delivery Business News.